Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplasm Metastasis × Denosumab × Clear all

Phase

Status

Completed 4 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 4 Prostatic Neoplasms 2 Ovarian Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Neoplasm Metastasis 1 Giant Cell Tumor of Bone 1 Carcinoma, Renal Cell 1

Interventions

pembrolizumab 23 Capecitabine 21 Cyclophosphamide 20 Bevacizumab 20 Gemcitabine 18 aldesleukin 17 Fluorouracil 17 Nivolumab 16 Docetaxel 16 Leucovorin 15 Paclitaxel 14 Irinotecan 14 Radiosurgery 13 Interleukin-2 13 fludarabine 12 Oxaliplatin 12 fludarabine phosphate 10 Drug Therapy 10 Cisplatin 10 Albumin-Bound Paclitaxel 10 Cetuximab 9 Carboplatin 9 Radiotherapy 8 Everolimus 8 Doxorubicin 8 Zoledronic Acid 7 Trastuzumab 7 Temozolomide 7 Sunitinib 7 Erlotinib Hydrochloride 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03869762 2024-09-25

DICE

Cancer Trials Ireland

Phase 2 Terminated

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡